Midodrine Medical Valley (Midodrine Hydrochloride)

Midodrine is a prodrug that is converted to desglymidodrine, which selectively activates peripheral alpha‑1 adrenergic receptors. This activation causes vasoconstriction of blood vessels, raising systemic vascular resistance and thereby increasing standing blood pressure.

The dosage of Midodrine Medical Valley is determined by the prescribing clinician based on the individual’s blood pressure response, severity of symptoms, and tolerability. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of midodrine in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Midodrine is unique as an oral alpha‑1 agonist that directly induces vasoconstriction, whereas other agents such as fludrocortisone increase blood volume. Midodrine often provides a faster rise in standing blood pressure, but individual response and side‑effect profiles guide the choice of therapy.

Midodrine tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Midodrine Medical Valley is taken orally, usually with a full glass of water. It is commonly prescribed to be taken during the day, avoiding doses within four hours of bedtime to reduce the risk of supine hypertension.

The most serious risks include severe or supine hypertension, which can lead to cardiovascular complications, and rare cases of ischemic events such as myocardial infarction or peripheral gangrene. Patients should be monitored closely for any signs of excessive blood pressure elevation.

Midodrine is contraindicated in patients with known hypersensitivity to the drug, severe organic heart disease, acute renal failure, or uncontrolled hypertension. It should also be avoided in individuals who cannot safely assume an upright position due to severe orthostatic intolerance.